Clinical Trial: A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients with ES-SCLC

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812260) titled 'A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients with ES-SCLC' on Jan. 22.

Brief Summary: Evaluate Clinical Efficacy, Safety and Pharmacokinetics of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Etoposide) in Previously Untreated Japanese Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: SCLC, Extensive Stage

Intervention: DRUG: HLX10+chemo

Treatment arm

Recruitment Status: NOT_YET_RECRUITING

Sponsor: S...